Clinical case seminar: Evidence for allograft rejection in an islet transplant recipient and effect on β-cell secretory capacity

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 7, 2007, Pages 2410-2414

  Rickels, Michael R ^a   Kamoun, Malek ^a   Kearns, Jane ^a   Markmann, James F ^a   Naji, Ali ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; DACLIZUMAB; GLUCOSE; HEMOGLOBIN A1C; HLA ANTIGEN CLASS 1; INSULIN GLARGINE; INSULIN LISPRO; ISOPHANE INSULIN; PREDNISONE; RAPAMYCIN; TACROLIMUS; ARGININE; DIAGNOSTIC AGENT; HLA ANTIGEN;

ADULT; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; BLOOD SAMPLING; CASE REPORT; CLINICAL FEATURE; COLITIS; COLON ULCER; CONFERENCE PAPER; DIARRHEA; DISEASE COURSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GRAFT RECIPIENT; GRAFT REJECTION; HLA TYPING; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTRAVENOUS GLUCOSE TOLERANCE TEST; KIDNEY GRAFT; LIVING DONOR; PANCREAS GRAFT REJECTION; PANCREAS ISLET BETA CELL; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; ALLOTRANSPLANTATION; ARTICLE; DONOR; HISTOCOMPATIBILITY TEST; IMMUNOLOGY; METABOLISM; PANCREAS ISLET TRANSPLANTATION; POSTOPERATIVE COMPLICATION; SECRETION; TRANSPLANTATION;

ADULT; ANTIBODY SPECIFICITY; ARGININE; DIABETES MELLITUS, TYPE 1; FEMALE; GLUCOSE; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 34447115728     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-0172     Document Type: Conference Paper

References (23)

1. Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, Kneteman NM, Lakey JRT, Shapir AMJ 2005 Five-year follow-up after clinical islet transplantation. Diabetes 54:2060-2069
2. Shapiro AM, Ricordi C, Hering BJ, Auchincloss H, Lindblad R, Robertson RP, Secchi A, Brendel MD, Berney T, Brennan DC, Cagliero E, Alejandro R, Ryan EA, DiMercurio B, Morel P, Polonsky KS, Reems JA, Bretzel RG, Bertuzzi F, Froud T, Kandaswamy R, Sutherland DE, Eisenbarth G, Segal M, Preiksaitis J, Korbutt GS, Barton FB, Viviano L, Seyfert-Margolis V, Bluestone J, Lakey JR 2006 International trial of the Edmonton protocol for islet transplantation. N Engl J Med 355:1318-1330
3. Roep BO, Stobbe I, Duinkerken G, van Rood JJ, Lernmark A, Keymeulen B, Pipeleers D, Claas FHJ, De Vries RRP 1999 Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients. Diabetes 48:484-490
4. Teuscher AU, Kendall DM, Smets YF, Leone JP, Sutherland DE, Robertson RP 1998 Successful islet autotransplantation in humans: functional insulin secretory reserve as an estimate of surviving islet cell mass. Diabetes 47:324-330
5. Rickels MR, Schutta MH, Markmann JF, Barker CF, Naji A, Teff KL 2005 β-Cell function following human islet transplantation for type 1 diabetes. Diabetes 54:100-106
6. The DCCT Research Group 1991 Epidemiology of severe hypoglycemia in the diabetes control and complications trial. Am J Med 90:450-459
7. Markmann JF, Deng S, Huang X, Desai NM, Velidedeoglu EH, Lui C, Frank A, Markmann E, Palanjian M, Brayman K, Wolf B, Bell E, Vitamaniuk M, Doliba N, Matschinsky F, Barker CF, Naji A 2003 Insulin independence following isolated islet transplantation and single islet infusions. Ann Surg 237:741-749
8. Frank A, Deng SP, Huang XL, Velidedeoglu E, Bae YS, Liu CY, Stephenson R, Mohiuddin M, Thambipillai T, Markmann E, Palanjian M, Sellers M, Naji A, Barker CF, Markmann JF 2004 Transplantation for type 1 diabetes-comparison of vascularized whole-organ pancreas with isolated pancreatic islets. Ann Surg 240:631-640
9. Bray RA, Lebeck LK, Gebel HM 1989 The flow cytometric crossmatch. Dual-color analysis of T cell and B cell reactivities. Transplantation 48:834-840
10. El Awar N, Lee J, Terasaki PI 2005 HLA antibody identification with single antigen beads compared to conventional methods. Hum Immunol 66:989-997
11. Ward WK, Halter JB, Beard JC, Porte Jr D 1984 Adaptation of B and A cell function during prolonged glucose infusion in human subjects. Am J Physiol 246 (5 Pt 1):E405-E411
12. Robertson RP 2004 AIRarg and AIRgluc as predictors of insulin secretory reserve. Transplant Proc 36:1040-1041
13. Brunzell JD, Robertson RP, Lerner RL, Hazzard WR, Ensinck JW, Bierman EL, Porte D 1976 Relationships between fasting plasma glucose levels and insulin-secretion during intravenous glucose-tolerance tests. J Clin Endocrinol Metab 42:222-229
14. Ganda OP, Srikanta S, Brink SJ, Morris MA, Gleason RE, Soeldner JS, Eisenbarth GS 1984 Differential sensitivity to β-cell secretagogues in early, type-I diabetes-mellitus. Diabetes 33:516-521
15. Lee PC, Terasaki PI, Takemoto SK, Lee PH, Hung CJ, Chen YL, Tsai A, Lei HY 2002 All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies. Transplantation 74:1192-1194
16. Mao Q, Terasaki PI, Cai J, Briley K, Catrou P, Haisch C, Rebellato L 2007 Extremely high association between appearance of HLA antibodies and failure of kidney grafts in a five-year longitudinal study. Am J Transplant 7:864-871
17. Olack BJ, Swanson CJ, Flavin KS, Phelan D, Brennan DC, White NH, Lacy PE, Scharp DW, Poindexter N, Mohanakumar T 1997 Sensitization to HLA antigens in islet recipients with failing transplants. Transplant Proc 29:2268-2269
18. Bosi E, Braghi S, Maffi P, Scirpoli M, Bertuzzi F, Pozza G, Secchi A, Bonifacio E 2001 Autoantibody response to islet transplantation in type 1 diabetes. Diabetes 50:2464-2471
19. Jaeger C, Brendel MD, Hering BJ, Eckhard M, Bretzel RG 1997 Progressive islet graft failure occurs significantly earlier in autoantibody-positive than in autoantibody-negative IDDM recipients of intrahepatic islet allografts. Diabetes 46:1907-1910
20. Worcester Human Islet Transplantation Group 2006 Autoimmunity after islet-cell allotransplantation. N Engl J Med 355:1397-1399
21. Hiller WFA, Klempnauer J, Luck R, Steiniger B 1991 Progressive deterioration of endocrine function after intraportal but not kidney subcapsular rat islet transplantation. Diabetes 40:134-140
22. Mattsson G, Jansson L, Nordin A, Andersson A, Carlsson PO 2004 Evidence of functional impairment of syngeneically transplanted mouse pancreatic islets retrieved from the liver. Diabetes 53:948-954
23. Desai NM, Goss JA, Deng S, Wolf B, Markmann E, Palanjian M, Shock A, Feliciano S, Brunicardi FC, Barker CF, Naji A, Markman JF 2003 Elevated portal vein drug levels of sirolimus and tacrolimus in islet transplant recipients: local immunosuppression or islet toxicity? Transplantation 76:1623-1625